Who
Patrice Rioux
Other role
Company insider
Files Form 4 as: Other, Monopar Therapeutics; Other, Raptor Pharmaceutical; Chief Medical Officer, Raptor Pharmaceuticals.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $223
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 16 Apr 2009
- Last trade
- 26 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 27 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | $71,380 at $0.005 | filing |
| 26 Aug 2026filed 27 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $1111 at $111.26 | filing |
| 26 Aug 2026filed 27 Aug 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,380 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,380 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | $141,380 at $0.01 | filing |
| 26 Aug 2026filed 27 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $1111 at $111.26 | filing |
| 1 Jan 2026filed 5 Jan 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 1 Jan 2026filed 5 Jan 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 1 Jan 2025filed 2 Jan 2025 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 1 Jan 2024filed 3 Jan 2024 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Jan 2023filed 3 Jan 2023 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Jan 2022filed 4 Jan 2022 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Jan 2021filed 5 Jan 2021 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 30 Jan 2020filed 20 Feb 2020 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,125 at $0.00 | filing |
| 26 Nov 2019filed 26 Nov 2019 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,333 at $0.00 | filing |
| 26 Nov 2019filed 26 Nov 2019 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —100 at $0.00 | filing |
| 26 Nov 2019filed 26 Nov 2019 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | $110K18,333 at $6.00 | filing |
| 26 Nov 2019filed 26 Nov 2019 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | —100 at $0.00 | filing |
| 30 Dec 2018filed 25 Jan 2019 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 25 Sep 2012filed 28 Sep 2012 | Raptor Pharmaceuticaloption or derivative | SEC FORM 4 Code A | —67,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.